Substituted anilide ligands for the thyroid receptor

Details Substituted anilide ligands for the thyroid receptor Substituted anilide ligands for the thyroid receptor

2004-01-23

2008-03-11

Puttlitz, Karl (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

C562S430000, C562S442000, C562S443000, C514S534000

Reexamination Certificate

active

07342127

ABSTRACT:
Novel thyroid receptor ligands are provided having the general formula IwhereinX, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12and R13are as defined herein.In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.

REFERENCES:
patent: 3239345 (1966-03-01), Hodge et al.
patent: 3983140 (1976-09-01), Endo et al.
patent: 4027009 (1977-05-01), Grier et al.
patent: 4036979 (1977-07-01), Asato
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4379785 (1983-04-01), Weyer et al.
patent: 4411890 (1983-10-01), Momany
patent: 4448784 (1984-05-01), Glamkowski et al.
patent: 4450171 (1984-05-01), Hoffman et al.
patent: 4499289 (1985-02-01), Baran et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4613610 (1986-09-01), Wareing
patent: 4639436 (1987-01-01), Junge et al.
patent: 4647576 (1987-03-01), Hoefle et al.
patent: 4681893 (1987-07-01), Roth
patent: 4686237 (1987-08-01), Anderson
patent: 4759923 (1988-07-01), Buntin et al.
patent: 4871721 (1989-10-01), Biller
patent: 4904769 (1990-02-01), Rauenbusch
patent: 4924024 (1990-05-01), Biller
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5011930 (1991-04-01), Fujikawa et al.
patent: 5177080 (1993-01-01), Angerbauer et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5273995 (1993-12-01), Roth
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5385929 (1995-01-01), Bjorge et al.
patent: 5401772 (1995-03-01), Yokoyama et al.
patent: 5488064 (1996-01-01), Sher
patent: 5491134 (1996-02-01), Sher et al.
patent: 5506219 (1996-04-01), Robl
patent: 5541204 (1996-07-01), Sher et al.
patent: 5594016 (1997-01-01), Ueno et al.
patent: 5595872 (1997-01-01), Wetterau, II et al.
patent: 5612359 (1997-03-01), Murugesan
patent: 5614492 (1997-03-01), Habener
patent: 5631224 (1997-05-01), Efendic et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 5691322 (1997-11-01), Robl
patent: 5712279 (1998-01-01), Biller et al.
patent: 5712396 (1998-01-01), Magnin et al.
patent: 5739135 (1998-04-01), Biller et al.
patent: 5753675 (1998-05-01), Wattanasin
patent: 5760246 (1998-06-01), Biller et al.
patent: 5770615 (1998-06-01), Cheng et al.
patent: 5776983 (1998-07-01), Washburn et al.
patent: 5827875 (1998-10-01), Dickson, Jr. et al.
patent: 5885983 (1999-03-01), Biller et al.
patent: 5962440 (1999-10-01), Sulsky
patent: 6043265 (2000-03-01), Murugesan et al.
patent: 6090854 (2000-07-01), Epperson
patent: 6184231 (2001-02-01), Hewawasam et al.
patent: 6664291 (2003-12-01), Chiang et al.
patent: 0 221 025 (1987-05-01), None
patent: 0 142 146 (1988-08-01), None
patent: 0 773 226 (1999-01-01), None
patent: 0 684 254 (1999-03-01), None
patent: 0 598 359 (2000-06-01), None
patent: 0 850 948 (2002-04-01), None
patent: 1 297 833 (2003-04-01), None
patent: 2 596 393 (1987-10-01), None
patent: 2 205 837 (1988-12-01), None
patent: 8-27006 (1996-01-01), None
patent: 9-124684 (1997-05-01), None
patent: 9-124685 (1997-05-01), None
patent: 9-188625 (1997-07-01), None
patent: 10-245391 (1998-09-01), None
patent: WO 86/03488 (1986-06-01), None
patent: WO 86/07054 (1986-12-01), None
patent: WO 89/07110 (1989-08-01), None
patent: WO 89/07111 (1989-08-01), None
patent: WO 93/04081 (1993-03-01), None
patent: WO 96/38144 (1996-12-01), None
patent: WO 97/12613 (1997-04-01), None
patent: WO 97/12615 (1997-04-01), None
patent: WO 97/21993 (1997-06-01), None
patent: WO 99/00353 (1999-01-01), None
patent: WO 99/38501 (1999-08-01), None
patent: WO 99/46272 (1999-09-01), None
patent: WO 99/61431 (1999-12-01), None
patent: WO 99/67278 (1999-12-01), None
patent: WO 99/67279 (1999-12-01), None
patent: WO 00/01389 (2000-01-01), None
patent: 01/60784 (2001-08-01), None
patent: WO 01/60784 (2001-08-01), None
patent: WO 01/70687 (2001-09-01), None
patent: WO 01/72692 (2001-10-01), None
patent: WO 01/85670 (2001-11-01), None
patent: WO 01/90053 (2001-11-01), None
patent: WO 01/94293 (2001-12-01), None
patent: WO 02/051805 (2002-07-01), None
patent: WO 02/062780 (2002-08-01), None
patent: WO 02/090344 (2002-11-01), None
patent: WO 02/094319 (2002-11-01), None
patent: WO 2004/018421 (2004-03-01), None
Silverman, Organic Chemistry of Drug Design (1992) pp. 19-23.
CAS online citation of [retrieved Feb. 21, 2007] from STN, Columbus, OH, USA, No. 2001:730688.
Ashworth, D.M. et al., “2-Cyanopyrrolidides as Potent, Stable Inhibitors of Dipeptidyl Peptidase IV”, Bioorganic & Medicinial Chemistry Letters, vol. 6, No. 10, pp. 1163-1166 (1996).
Ashworth, D.M. et al., “4-Cyanothiazolidides as Very Potent, Stable Inhibitors of Dipeptidyl Peptidase IV”, Bioorganic & Medicinial Chemistry Letters, vol. 6, No. 22, pp. 2745-2748 (1996).
Biller, S.A. et al., “Isoprenoid (Phosphinylmethyl)phosphonates as Inhibitors of Squalene Synthetase”, Journal of Medicinal Chemistry, vol. 31, No. 10, pp. 1869-1871 (1988).
Biller, S.A. et al., “Squalene Synthase Inhibitors”, Current Pharmaceutical Design, vol. 2, No. 1, pp. 1-40 (1996).
Bundgaard, H., Chapter 5: “Design and Application of Prodrugs”, A Textbook of Drug Design and Development, Harwood Academic Publishers, publ., Krogsgaard-Larsen, P. et al., eds., pp. 113-191 (1991).
Bundgaard, H., ed., Design of Prodrugs, Elsevier Science Publishers B.V., publ. (1985) (table of contents).
Capson, T.L., “Synthesis and Evaluation of Ammonium Analogs of Carbocationic Intermediates in Squalene Biosynthesis”, dissertation, Department of Medicinal Chemistry, University of Utah, pp. iv-v, Table of Contents, 16-17, 40-43, 48-51, Summary (Jun. 1987).
Chakrabartty, S.K., Chapter V: “Alkaline Hypohalite Oxidations”, Oxidation in Organic Chemistry, Part C, Academic Press, Inc., publ., Trahanovsky, W.S., ed., pp. 343-370 (1978).
Chan, D.M.T. et al., “New N- and O-Arylations with Phenylboronic Acids and Cupric Acetate”, Tetrahedron Letters, vol. 39, pp. 2933-2936 (1998).
Chiellini, G. et al., “A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor”, Chemistry & Biology, vol. 5, No. 6, pp. 299-306 (1998).
Corey, E.J. et al., “Application of Unreactive Analogs of Terpenoid Pyrophosphates to Studies of Multistep Biosynthesis. Demonstration That ‘Presqualene Pyrophosphate’ Is an Essential Intermediate on the Path to Squalene”, J. Am. Chem. Soc., vol. 98, No. 5, pp. 1291-1293 (1976).
Cornicelli, J.A. et al., “15-Lipoxygenase and Its Inhibition: A Novel Therapeutic Target for Vascular Disease”, Current Pharmaceutical Design, vol. 5, No. 1, pp. 11-20 (1999).
Couladouros, E.A. et al., “A general synthetic route towards bastadins. Part 1: Synthesis of the eastern part of bastadins 4-16”, Tetrahedron Letters, vol. 40, pp. 7023-7026 (1999).
Dibbo, A. et al., “The Synthesis of Thyroxine and Related Compounds. Part XVII. The Preparation of Some Additional Compounds related to Thyroxine”, J. Chem. Soc., pp. 2890-2902 (1961).
Driver, M.S. et al., “A Second-Generation Catalyst for Aryl Halide Amination: Mixed Secondary Amines from Aryl Halides and Primary Amines Catalyzed by (DPPF)PdCl2”, J. Am. Chem. Soc., vol. 118, No. 30, pp. 7217-7218 (1996).
Edwards, J.P. et al., “Nonsteroidal Androgen Receptor Agonists Based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one”, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1003-1008 (1999).
Evans, D.A. et al., “Synthesis of Diaryl Ethers through the Copper-Promoted Arylation of Phenols with Arylboronic Acids. An Expedient Synthesis of Thyroxine”, Tetrahedron Letters, vol. 39, pp. 2937-2940 (1998).
Frost, C.G. et al., “Recent developments in aromatic heteroatom coupling reactions”, J. Chem. Soc., Perkin Trans. 1, pp. 2615-2623

Affiliated with

Also associated with

Rating

Substituted anilide ligands for the thyroid receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted anilide ligands for the thyroid receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted anilide ligands for the thyroid receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3976478